drugset

drugset / Trial / NCT02245711

Cell Therapy in Limb Girdle Muscular Dystrophy

NCT02245711 ↗

Phase 1 Withdrawn Neurogen Brain and Spine Institute

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study was to study the effect of stem cell therapy on Limb Girdle Muscular Dystrophy patients.

Timeline

Start: 2010-12
Primary completion: 2015-01
Completion: 2015-06

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Stem Cell	Cell therapy	—	Intrathecal

Indications